520 related articles for article (PubMed ID: 23842215)
41. Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.
Salerno F; Badalamenti S; Moser P; Lorenzano E; Incerti P; Dioguardi N
Gastroenterology; 1990 Apr; 98(4):1063-70. PubMed ID: 2138104
[TBL] [Abstract][Full Text] [Related]
42. [Albumin infusion for paracentesis in patients with cirrhosis: dogma or evidence?].
Manzocchi S; Nendaz M; Spahr L
Rev Med Suisse; 2012 Oct; 8(358):1956, 1958-60. PubMed ID: 23198648
[TBL] [Abstract][Full Text] [Related]
43. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.
Bernardi M; Caraceni P; Navickis RJ; Wilkes MM
Hepatology; 2012 Apr; 55(4):1172-81. PubMed ID: 22095893
[TBL] [Abstract][Full Text] [Related]
44. AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis.
;
Dig Liver Dis; 2016 Jan; 48(1):4-15. PubMed ID: 26802734
[TBL] [Abstract][Full Text] [Related]
45. Midodrine and clonidine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
Singh V; Singh A; Singh B; Vijayvergiya R; Sharma N; Ghai A; Bhalla A
Am J Gastroenterol; 2013 Apr; 108(4):560-7. PubMed ID: 23419385
[TBL] [Abstract][Full Text] [Related]
46. Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites.
Salerno F; Badalamenti S; Lorenzano E; Moser P; Incerti P
Hepatology; 1991 Apr; 13(4):707-13. PubMed ID: 1826281
[TBL] [Abstract][Full Text] [Related]
47. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
[TBL] [Abstract][Full Text] [Related]
48. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
Arroyo V; Ginès P; Planas R
Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
[TBL] [Abstract][Full Text] [Related]
49. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis.
Altman C; Bernard B; Roulot D; Vitte RL; Ink O
Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):5-10. PubMed ID: 9512946
[TBL] [Abstract][Full Text] [Related]
50. Midodrine versus Albumin to Prevent Paracentesis Induced Circulatory Dysfunction in Acute on Chronic Liver Failure Patients in the Outpatient Clinic-a Randomized Controlled Trial.
Sujith Reddy JSN; Jagtap N; Kalpala R; Kulkarni A; Gupta R; Nagaraja Rao P; Iyengar S; Alla M; Nageshwar Reddy D; Sharma M
J Clin Exp Hepatol; 2023; 13(4):576-585. PubMed ID: 37440947
[TBL] [Abstract][Full Text] [Related]
51. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
[TBL] [Abstract][Full Text] [Related]
52. Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites.
Kalambokis G; Fotopoulos A; Economou M; Pappas K; Tsianos EV
J Hepatol; 2007 Feb; 46(2):213-21. PubMed ID: 17156883
[TBL] [Abstract][Full Text] [Related]
53. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
Wong F; Raina N; Richardson R
Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
[TBL] [Abstract][Full Text] [Related]
54. [Paracentesis combined with albumin infusion in the treatment of tense ascites in cirrhotic patients].
Chesta J; Brahm J; Latorre R; Gidi J; Hurtado C; Antezana C; Novoa X; Velasco M
Rev Med Chil; 1990 Aug; 118(8):874-80. PubMed ID: 2152231
[TBL] [Abstract][Full Text] [Related]
55. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
[TBL] [Abstract][Full Text] [Related]
56. Is albumin infusion necessary after large volume paracentesis?
Cárdenas A; Ginès P; Runyon BA
Liver Int; 2009 May; 29(5):636-40; discussion 640-1. PubMed ID: 19413666
[No Abstract] [Full Text] [Related]
57. Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study.
Fassio E; Terg R; Landeira G; Abecasis R; Salemne M; Podesta A; Rodriguez P; Levi D; Kravetz D
J Hepatol; 1992 Mar; 14(2-3):310-6. PubMed ID: 1380024
[TBL] [Abstract][Full Text] [Related]
58. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites.
Titó L; Ginès P; Arroyo V; Planas R; Panés J; Rimola A; Llach J; Humbert P; Badalamenti S; Jiménez W
Gastroenterology; 1990 Jan; 98(1):146-51. PubMed ID: 2293573
[TBL] [Abstract][Full Text] [Related]
59. Hemodynamic changes in patients developing effective hypovolemia after total paracentesis.
Vila MC; Solà R; Molina L; Andreu M; Coll S; Gana J; Marquez J; Palá J; Bory F; Pons S; Szescielinski L; Jimenez W
J Hepatol; 1998 Apr; 28(4):639-45. PubMed ID: 9566833
[TBL] [Abstract][Full Text] [Related]
60. Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: a case-control study.
Alessandria C; Debernardi-Venon W; Carello M; Ceretto S; Rizzetto M; Marzano A
Dig Liver Dis; 2009 Apr; 41(4):298-302. PubMed ID: 19158001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
